The purpose of double blinding in clinical trials is to:
High-Yield Explanation
Single blind: Only patients or only investigators are ignorant of assigned treatment.
Double blind: Patients & investigators are ignorant of assigned treatment.
Triple blind: Patients, investigators & data evaluators are ignorant of assigned treatment.